Literature DB >> 31102089

ASO Author Reflections: Variation in the Use of Chemoprevention According to Breast Cancer Risk Factor.

Meghan R Flanagan1, Melissa L Pilewskie2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31102089      PMCID： PMC6858936          DOI： 10.1245/s10434-019-07460-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor.

Authors:  Meghan R Flanagan; Emily C Zabor; Michelle Stempel; Debra A Mangino; Monica Morrow; Melissa L Pilewskie
Journal:  Ann Surg Oncol       Date:  2019-02-27       Impact factor: 5.344

2.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

Review 3.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Authors:  Jack Cuzick; Ivana Sestak; Bernardo Bonanni; Joseph P Costantino; Steve Cummings; Andrea DeCensi; Mitch Dowsett; John F Forbes; Leslie Ford; Andrea Z LaCroix; John Mershon; Bruce H Mitlak; Trevor Powles; Umberto Veronesi; Victor Vogel; D Lawrence Wickerham
Journal:  Lancet       Date:  2013-04-30       Impact factor: 79.321

Review 4.  Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.

Authors:  S G Smith; I Sestak; A Forster; A Partridge; L Side; M S Wolf; R Horne; J Wardle; J Cuzick
Journal:  Ann Oncol       Date:  2015-12-08       Impact factor: 32.976
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.